InvestorsHub Logo
Followers 12
Posts 1019
Boards Moderated 0
Alias Born 03/24/2013

Re: KCSVEN post# 15244

Tuesday, 10/01/2013 2:51:10 PM

Tuesday, October 01, 2013 2:51:10 PM

Post# of 426316
why they need to prove they can sell >bn$ a year?
They have a ++superior product compared to a bn$ product (Lovaza). That's enough to make even a dumb believe Vascepa can sell bn$ a year.

Profitability....
Why PCYC has a MCap of >10bn$ ? They are at-least 6 months away from approval and probably 9 months away from launch of first product and probably few year(s) away from profitability. If one can answer that, AMRN doesn't need to show profitability to WS for a 5-6bn MCap valuation.

Bottomline
AMRN is drastically undervalued. Can't say it any better.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News